Abstract Body

This talk will review current the status of the hepatitis C virus (HCV) epidemic in the US and globally, focusing on progress and impediments to meeting elimination goals. Dr Luetkemeyer will review models of successful widespread treatment and micro-elimination and strategies to address remaining barriers to elimination, including lessons learned from COVID-19 and approaches to highly impacted populations.